Aislinn Antrim's profile photo

Aislinn Antrim

Associate Editor at Pharmacy Times

Journalist at Pharmacy Times | UNC '19 | Interests in politics, long-form storytelling, and cats

Featured in: Favicon pharmacytimes.com Favicon wral.com Favicon journalnow.com Favicon newsbreak.com Favicon dailytarheel.com Favicon ajmc.com Favicon newsmaven.io Favicon contemporaryobgyn.net Favicon ednc.org Favicon patientcareonline.com

Articles

  • FDA Approves Dupilumb for Treatment of Bullous Pemphigoid

    1 week ago | pharmacytimes.com | Aislinn Antrim

    FDA officials approved dupilumab (Dupixent; Sanofi, Regeneron) for the treatment of adults with bullous pemphigoid (BP), marking the first and only targeted treatment for BP.1 The supplemental biologics license application was accepted by the FDA for priority review in February 2025.2BP is a chronic, debilitating, and relapsing skin condition with underlying type 2 inflammation.

  • Concierge Pharmacy's Role in Cardio-Kidney-Metabolic Health Care

    1 week ago | pharmacytimes.com | Craig Beavers |BCPSAQ Cardiology |Aislinn Antrim

    CommentaryPodcastJune 17, 2025Author(s):,Host Craig Beavers chats with Shannon Finks, PharmD, FCCP, BCPS, BCCP, AHSCP-CHC, president and director of pharmacy services at ZupMed in Memphis, Tennessee. Host Craig Beavers, PharmD, FACC, FAHA, FCCP, BCCP, CACP, chats with Shannon Finks, PharmD, FCCP, BCPS, BCCP, AHSCP-CHC, president and director of pharmacy services at ZupMed in Memphis, Tennessee.

  • Pharmacy Policy Updates for June 2025

    1 week ago | pharmacytimes.com | Aislinn Antrim |Alexandra Gerlach |Luke Halpern

    Executive Order Aims to Lower Prescription Drug CostsPresident Donald J. Trump has signed an executive order that aims to reduce drug costs for Americans and tie them to what other nations pay for medications.

  • Inpatient Biosimilar Use Grows, Offering Cost-Saving Opportunities for Health Systems

    2 weeks ago | pharmacytimes.com | Aislinn Antrim

    A comprehensive analysis of inpatient biologic and biosimilar use over 6 years reveals significant growth in biosimilar adoption, highlighting a valuable financial opportunity for pharmacy departments and health systems.

  • Pharmacist-Led HCV Program Uncovers Syndemic Risks, Supports Expanded Screening

    2 weeks ago | pharmacytimes.com | Aislinn Antrim

    A pharmacist-led initiative to screen and treat hepatitis C virus (HCV) in the emergency department (ED) has dramatically improved treatment outcomes and unveiled critical gaps in care for other syndemic infections, according to new research presented at the American Society of Health-System Pharmacists (ASHP) 2025 Pharmacy Futures meeting.1The study, conducted at University of Kentucky Healthcare, evaluated over 33,000 patients screened for HCV between June 2023 and June 2024.

Contact details

Emails

[email protected]

Socials & Sites

Try JournoFinder For Free

Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.

Start Your 7-Day Free Trial →

X (formerly Twitter)

Followers
56
Tweets
107
DMs Open
No
Aislinn Antrim
Aislinn Antrim @AislinnAntrim
6 Aug 22

Great conversation with Michael Ganio of @ASHPOfficial!

Pharmacy Times
Pharmacy Times @Pharmacy_Times

Michael Ganio, PharmD, senior director of pharmacy practice and quality at ASHP, discusses the declaration of #monkeypox as a public health emergency, as well as pharmacists’ roles in educating patients. Watch More Here: https://t.co/lJL8zMyU3u https://t.co/FrUVLdvuek

Aislinn Antrim
Aislinn Antrim @AislinnAntrim
11 Jul 22

"This historic application marks a groundbreaking moment in contraceptive access and reproductive quality," said Frederique Welgryn of HRA Pharma.

Pharmacy Times
Pharmacy Times @Pharmacy_Times

#BREAKING: FDA to Review Application for First-Ever OTC Birth Control Pill Learn more: https://t.co/bkuJ1gHh01 https://t.co/LFXjUxRdue

Aislinn Antrim
Aislinn Antrim @AislinnAntrim
9 Jul 22

Loving McKesson #ideaShare2022! https://t.co/e2oldROqkM